Skip to content
Search

Latest Stories

Get Winter Strong: 18,000 flu-related deaths in past 2 winters

Get Winter Strong: 18,000 flu-related deaths in past 2 winters

Flu vaccine uptake rates dropped last winter across all eligible groups in England compared to the previous year

The UK Health Security Agency (UKHSA), in collaboration with the Department of Health and Social Care and NHS England, is set to launch a scaled-up Get Winter Strong campaign on October 7 to help mitigate the impact of winter viruses, such as flu and COVID-19, on vulnerable populations and ease NHS winter pressures.

At least 18,000 deaths were associated with flu over the past 2 winters (October to May, 2022-2023 and 2023-2024), even though last winter was comparatively mild for flu, according to the latest UKHSA data.


Flu is a deadly virus, particularly for older people and other groups at greatest risk. Getting vaccinated ahead of winter is the most effective way to safeguard against the virus.

Concerningly, flu vaccine uptake rates dropped last winter across all eligible groups in England compared to the previous year.

Although uptake among older adults remained high, only 41 per cent people with long-term health conditions, 44 per cent of 2- and 3-year-olds, and just one in three pregnant women received the flu vaccine.

During the same two-year winter period, an estimated 19,500 deaths were linked to COVID-19.

The expanded Get Winter Strong campaign will encourage eligible individuals to receive their flu and COVID-19 vaccinations when invited, ahead of winter, targeting those at greatest risk.

For the first time, the campaign will also promote respiratory syncytial virus (RSV) and whooping cough vaccinations for pregnant women.

The maternal vaccine provides strong protection for newborns in their first few months when they are most at risk of severe illness from RSV.

Older people aged 75 to 79 are also eligible for RSV vaccination this year.

Dr Gayatri Amirthalingam, UKHSA Deputy Director of Immunisation, said: “As winter approaches we see many dangerous viruses circulating in our communities including flu, which tragically can kill thousands of people every year. Getting vaccinated ahead of winter is by far your best defence.

If you’re pregnant or have certain long-term health conditions, you are at greater risk of getting seriously ill. Older people and young infants with flu are also much more likely to get hospitalised.

So if you or your child are offered the flu, COVID-19 or RSV vaccines, don’t delay in getting them. Please speak to your nurse or doctor if you have any concerns.”

Steve Russell, NHS National Director for Vaccinations and Screening, has urged those who are eligible to book their vaccine appointment as soon as they can, stating that “it is our best way of protecting those who are vulnerable as winter approaches.”

The Get Winter Strong campaign will run for 10 weeks.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less